跳到正文

RA Capital Nexus Fund, L.P. 内部人交易:近期 SEC Form 4 交易

过去 18 个月,RA Capital Nexus Fund, L.P.(CIK 1780117)在 7 家公司共报告 110 笔 SEC Form 4 内部人交易(最近一笔 2026-09-30)。

日期公司身份类型股数市值
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$34,600
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$30,000
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$78,900
2026-09-30Climb Bio, Inc. (CLYM)董事买入40,000$51,600
2026-09-21Sionna Therapeutics, Inc. (SION)董事卖出3.4M$21.6M
2026-09-21Sionna Therapeutics, Inc. (SION)董事卖出33,800$252,148
2026-07-31Artiva Biotherapeutics, Inc. (ARTV)董事买入20,824$208,032
2026-07-31Artiva Biotherapeutics, Inc. (ARTV)董事买入24,944$247,694
2026-07-28Artiva Biotherapeutics, Inc. (ARTV)董事买入41,319$412,777
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入59,880$596,405
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入120,582$1.2M
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入84,124$835,351
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入6,522$58,307
2026-07-22Freenome, Inc. (FRNM)董事买入6.6M$0
2026-07-22Freenome, Inc. (FRNM)董事买入970,950$0
2026-07-22Freenome, Inc. (FRNM)董事买入553,703$0
2026-07-22Freenome, Inc. (FRNM)董事买入908,103$0
2026-07-22Freenome, Inc. (FRNM)董事买入367,427$0
2026-07-22Freenome, Inc. (FRNM)董事买入4.9M$49.2M
2026-07-22Freenome, Inc. (FRNM)董事买入336,965$3.4M
2026-07-20Artiva Biotherapeutics, Inc. (ARTV)董事买入152,472$1.4M
2026-07-20Artiva Biotherapeutics, Inc. (ARTV)董事买入7,882$70,544
2026-07-14Artiva Biotherapeutics, Inc. (ARTV)董事买入15,102$135,465
2026-07-14Artiva Biotherapeutics, Inc. (ARTV)董事买入6,552$58,575
2026-06-29Artiva Biotherapeutics, Inc. (ARTV)董事买入31,000$275,280

来源:SEC Form 4 申报文件 · 截至 2026-09-30